SAUBOIN Economics Immunization approval revised version_HE_STREP_simple_Mod_GAVI

SAUBOIN Economics Immunization approval revised version_HE_STREP_simple_Mod_GAVI.pptx 14/10/16 Estimates of the potential public health impact and cost-effectiveness of adopting pneumococcal vaccination in the routine immunization programme in African GAVI countries: a modelling study C. [...] in Disease Control Priorities, Third edition, 2016 2 1 Deaths (%) 14/10/16 Objectives To estimate the potential public health impact and cost-effectiveness of pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) versus no vaccination in 36 African GAVI countries 3 Methods: Model structure •  A decision-tree model was used to assess the vaccine impact in children u. [...] •  Limitations in this study are related to the limitations from the original estimates of disease incidence and costs. [...] ISPPD 2016 conference, Abstract 143 11 Conclusions •  The implementation of PHiD-CV is projected to have a substantial public health impact •  The impact on the pneumonia burden would be the largest. [...] Editorial support of the related abstract were provided respectively by Abdelilah Ibrahimi (XPE Pharma & Science, on behalf of GSK Vaccines) All Authors are employees of the GSK group of companies and hold shares in the GSK group of companies as part of their employee remuneration.